Overview

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study will compare the safety and effectiveness of three different antipsychotic medications, as well as the use of other medications to limit treatment side effects, in adults with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Antipsychotic Agents
Aripiprazole
Benztropine
Metformin
Olanzapine
Perphenazine
Simvastatin